Приказ основних података о документу

dc.creatorVučićević, Katarina
dc.creatorMiljković, Branislava
dc.creatorGolubović, Bojana
dc.creatorJovanović, Marija
dc.creatorVezmar-Kovačević, Sandra
dc.creatorĆulafić, Milica
dc.creatorKovačević, Milena
dc.creatorde Gier, Johan J.
dc.date.accessioned2019-09-02T11:59:42Z
dc.date.available2019-09-02T11:59:42Z
dc.date.issued2017
dc.identifier.issn1381-4788
dc.identifier.urihttps://farfar.pharmacy.bg.ac.rs/handle/123456789/2892
dc.description.abstractBackground: During the initiation of treatment of a chronic disease, patients may have varying interests, expectations, concerns, and reasons to stop treatment, influencing compliance with prescribed treatment. Thus, healthcare professionals are expected to integrate these needs into medicines management. Objectives: To determine what information is important to patients; assess predictors of patients' interests, expectations, concerns, reasons to stop therapy; evaluate drug-related problems following initiation of therapy and summarize how pharmacists resolve them during patient-pharmacist counselling. Methods: In 2014, a four-month study was performed in Serbian community pharmacies, as part of the Pharmaceutical Care Quality Indicators Project led by the European Directorate for the Quality of Medicines & Healthcare. Seventy community pharmacists were asked to participate in the study. Pharmacists recruited adult patients who consented to participate in the study and who initiated treatment, lasting at least six months. Patients completed an open-ended questions form. After two-to-four weeks, a patient-pharmacist consultation was performed. Results: Forty-four community pharmacists (response rate 62.9%) sent back the completed forms from 391 patients (response rate 67.1%). The total number of dispensed drugs was 403. In terms of drug safety, 29.4% of patients sought information, 32.5% expressed concerns, and 28.1% of patients cited it as a reason to discontinue treatment. During the first weeks of therapy, 18% of patients experienced practical problems, while 27.3% reported adverse drug reactions. Conclusion: Safety issues are a major focus of patients' prescribed new medicines for long-term treatment.en
dc.publisherTaylor & Francis Ltd, Abingdon
dc.relationMinistry of Education, Science and Technological Development, Republic of Serbia
dc.rightsopenAccess
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/
dc.sourceEuropean Journal of General Practice
dc.subjectSafetyen
dc.subjectlong-term treatmenten
dc.subjectcommunity pharmacyen
dc.subjectpatient-pharmacist counsellingen
dc.titleExpectations, concerns, and needs of patients who start drugs for chronic conditions. A prospective observational study among community pharmacies in Serbiaen
dc.typearticle
dc.rights.licenseBY
dcterms.abstractде Гиер, Јохан Ј.; Голубовић, Бојана; Вучићевић, Катарина; Ковачевић, Милена; Јовановић, Марија; Ћулафић, Милица; Миљковић, Бранислава; Везмар-Ковачевић, Сандра;
dc.citation.volume24
dc.citation.issue1
dc.citation.spage19
dc.citation.epage25
dc.citation.other24(1): 19-25
dc.citation.rankM22
dc.identifier.wos000425954300001
dc.identifier.doi10.1080/13814788.2017.1388778
dc.identifier.pmid29164957
dc.identifier.scopus2-s2.0-85034657031
dc.identifier.fulltexthttps://farfar.pharmacy.bg.ac.rs//bitstream/id/1511/2890.pdf
dc.type.versionpublishedVersion


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу